Delivery Order SPE2DB20D3103-SPE2DB25FP6D7
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $16,283.25 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,153.78 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Betaseron 0.3 mg kits with a contract value of $36,290.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order operates...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Betaseron 0.3 mg kits. The $90,870.24 firm fixed-price contract has a completion date of September 24, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for delivering a wide range of medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirteen thousand four hundred ninety-nine dollars and ninety-four cents ($13,499.94) to Amerisourcebergen Drug Corporation for 4561479328 units of Betaseron 0.3 mg kits. Performance will take place in Conshohocken, Pennsylvania under a one day period from July 12, 2023 through July 13, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for the multiple...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $16,226.87 firm-fixed-price delivery order is for the medication Betaseron 0.3 mg kits. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a substantial...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at forty-two thousand one hundred fifty-six dollars and forty-five cents ($42,156.45) to Amerisourcebergen Drug Corporation for 4561948784 Betaseron 0.3 mg kits. The contract has a period of performance from August 25, 2023 through August 28, 2023, with all work to be completed at the prime contractor's facility located in Conshohocken, Pennsylvania. Betaseron is a drug used to treat multiple sclerosis. As the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $30,974.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply Betaseron 0.3 mg kits. The delivery order was awarded on December 11, 2023 against an existing indefinite delivery contract held by Amerisourcebergen Drug Corp, with performance to be completed by December 12, 2023. The delivery location is Amerisourcebergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6D7Delivery Order
The Defense Logistics Agency awarded a $34,669.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of July 24, 2025. This competitively awarded contract, issued on July 23, 2025, carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. As the prime contractor on this delivery order, the company will furnish Betaseron, a therapeutic pharmaceutical used in neurological treatment applications, leveraging its established position as a critical vendor within the DLA's global pharmaceutical support framework. This transaction exemplifies the ongoing medical supply chain operations through which AmerisourceBergen supports the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 7/23/25 |